Related Experiment Video
Updated: Nov 6, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Circular RNA circitga7 accelerates glioma progression via miR-34a-5p/VEGFA axis
Ling Qi1,2, Weiyao Wang1,2, Guifang Zhao1,3
1The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, Guangdong, China.
Abstract:
Circular RNAs (circRNAs) are a group of noncoding RNAs derived from back-splicing events. CircRNA is reported to be involved in various tumor progressions, including glioma. Although there are a few reports of circular RNAs participating in gliomas, it is still unclear whether circular RNAs regulate the occurrence of gliomas. In our research, we found that the expression of circITGA7 in glioma tissues and glioma cells increased significantly. Knocking down circITGA7 can significantly inhibit the proliferation of glioma cells and reduce cell metastasis. Through analysis and dual-luciferase report assay, we found that circITGA7 acts as a sponge for miR-34a-5p targeting VEGFA in glioma. Our study showed that circITGA7 regulates the proliferation and metastasis of glioma cell lines (SW1783&U373) by regulating the miR-34a-5p/VEGFA pathway. In conclusion, our study revealed a regulatory loop for the circITGA7/miR-34a-5p/VEGFA axis to regulate glioma development.
Insights
Circular RNAs (circRNAs) regulate glioma development. This study found circITGA7 promotes glioma cell proliferation and metastasis by sponging miR-34a-5p, impacting the VEGFA pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are noncoding RNAs implicated in tumor progression.
- The specific role of circRNAs in glioma development remains largely undefined.
- Glioma is a primary brain tumor with significant mortality.
Purpose of the Study:
- To investigate the role of circRNAs in glioma.
- To elucidate the mechanism by which circRNAs regulate glioma cell behavior.
- To identify potential therapeutic targets for glioma treatment.
Main Methods:
- Quantitative real-time PCR to measure circRNA expression.
- Cell proliferation and metastasis assays in glioma cell lines.
- Dual-luciferase reporter assay to confirm molecular interactions.
Main Results:
- circITGA7 expression was significantly upregulated in glioma tissues and cells.
- Knockdown of circITGA7 inhibited glioma cell proliferation and metastasis.
- circITGA7 functions as a molecular sponge for miR-34a-5p, regulating VEGFA.
Conclusions:
- circITGA7 promotes glioma progression by modulating the miR-34a-5p/VEGFA pathway.
- The circITGA7/miR-34a-5p/VEGFA axis represents a novel regulatory mechanism in glioma.
- circITGA7 is a potential therapeutic target for glioma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
MicroRNAs
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

